- Home
- LFCR vs MYO Comparison
LFCR vs MYO Comparison
Compare LFCR & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFCR
- MYO
- Stock Information
- Founded
- LFCR 1986
- MYO 2004
- Country
- LFCR United States
- MYO United States
- Employees
- LFCR N/A
- MYO N/A
- Industry
- LFCR Biotechnology: Pharmaceutical Preparations
- MYO Industrial Specialties
- Sector
- LFCR Health Care
- MYO Health Care
- Exchange
- LFCR Nasdaq
- MYO Nasdaq
- Market Cap
- LFCR 224.6M
- MYO 211.9M
- IPO Year
- LFCR N/A
- MYO 2017
- Fundamental
- Price
- LFCR $6.36
- MYO $5.07
- Analyst Decision
- LFCR Buy
- MYO Strong Buy
- Analyst Count
- LFCR 3
- MYO 4
- Target Price
- LFCR $8.00
- MYO $9.25
- AVG Volume (30 Days)
- LFCR 127.8K
- MYO 586.2K
- Earning Date
- LFCR 01-02-2025
- MYO 03-10-2025
- Dividend Yield
- LFCR N/A
- MYO N/A
- EPS Growth
- LFCR N/A
- MYO N/A
- EPS
- LFCR N/A
- MYO N/A
- Revenue
- LFCR $130,858,000.00
- MYO $32,551,198.00
- Revenue This Year
- LFCR $2.24
- MYO $32.15
- Revenue Next Year
- LFCR $7.88
- MYO $17.59
- P/E Ratio
- LFCR N/A
- MYO N/A
- Revenue Growth
- LFCR 16.47
- MYO 69.17
- 52 Week Low
- LFCR $3.68
- MYO $2.51
- 52 Week High
- LFCR $7.99
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- LFCR 58.66
- MYO 46.50
- Support Level
- LFCR $6.00
- MYO $4.12
- Resistance Level
- LFCR $5.96
- MYO $6.30
- Average True Range (ATR)
- LFCR 0.29
- MYO 0.42
- MACD
- LFCR 0.09
- MYO 0.05
- Stochastic Oscillator
- LFCR 81.51
- MYO 43.58
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).